Ueda Chiyoko, Akasaka Takashi, Kurata Masayuki, Maesako Yoshitomo, Nishikori Momoko, Ichinohasama Ryo, Imada Kazunori, Uchiyama Takashi, Ohno Hitoshi
First Division, Department of Internal Medicine, Faculty of Medicine, Kyoto University, 54 Shogoin-Kawaramachi, Sakyo-ku, Kyoto 606-8507, Japan.
Oncogene. 2002 Jan 17;21(3):368-76. doi: 10.1038/sj.onc.1205099.
BCL6 translocation affecting the chromosomal band 3q27 can involve a number of non-immunoglobulin (non-IG) gene loci as partners. We report here that the gene for interleukin-21 receptor (IL-21R) is the partner of BCL6 in t(3;16)(q27;p11) translocation. The two breakpoints on 16p11 of a lymphoma cell line YM and case no. 1012 with diffuse large B-cell lymphoma, both of which carried t(3;16), were localized within the 27-kb intron 1 of IL-21R. As a result of t(3;16), the promoter region of IL-21R was substituted for the regulatory sequences of BCL6 in the same transcriptional orientation. Reverse transcriptase-mediated polymerase chain reaction revealed chimeric mRNA consisting of two non-coding exons 1a/1b of IL-21R and coding exons of BCL6 in both lymphoma cells. Fluorescence in situ chromosomal hybridization of YM metaphase cells revealed fusion signals that contained both the BCL6 and IL-21R sequences on the der(3)t(3;16) chromosome. IL-21R was actively transcribed in YM cells, while BCL6 that was under the control of the IL-21R promoter was only moderately expressed at the mRNA and protein level. We constructed expression plasmid of BCL6 that followed the promoter sequences of IL-21R. COS-7 cells transiently transfected with the plasmid expressed high level Bcl-6 protein and displayed nuclear staining with a characteristic punctate pattern by immunofluorescence, indicating that expression of BCL6 can be enhanced by t(3;16). This study added to the list of non-IG partners of BCL6 translocations a new class of gene, i.e. cytokine receptor gene, the expression of which is closely associated with lymphoid cells.
影响染色体带3q27的BCL6易位可涉及多个非免疫球蛋白(非IG)基因座作为伙伴基因。我们在此报告,白细胞介素-21受体(IL-21R)基因是t(3;16)(q27;p11)易位中BCL6的伙伴基因。淋巴瘤细胞系YM和1012号弥漫性大B细胞淋巴瘤病例(二者均携带t(3;16))在16p11上的两个断点均位于IL-21R的27 kb内含子1内。由于t(3;16),IL-21R的启动子区域以相同转录方向取代了BCL6的调控序列。逆转录酶介导的聚合酶链反应显示,两种淋巴瘤细胞中均存在由IL-21R的两个非编码外显子1a/1b和BCL6的编码外显子组成的嵌合mRNA。YM中期细胞的荧光原位染色体杂交显示,在der(3)t(3;16)染色体上存在同时包含BCL6和IL-21R序列的融合信号。IL-21R在YM细胞中活跃转录,而受IL-21R启动子控制的BCL6在mRNA和蛋白水平仅中度表达。我们构建了遵循IL-21R启动子序列的BCL6表达质粒。用该质粒瞬时转染的COS-7细胞表达高水平的Bcl-6蛋白,并通过免疫荧光显示出具有特征性点状模式的核染色,表明t(3;16)可增强BCL6的表达。本研究在BCL6易位的非IG伙伴基因列表中增加了一类新基因,即细胞因子受体基因,其表达与淋巴细胞密切相关。